(Q40246564)

18 September 2017

title

Phosphorothioate analogues of alkyl lysophosphatidic acid as LPA3 receptor-selective agonists (English)

1 reference

18 September 2017

5

1 reference

18 September 2017

9

Gordon B Mills

1 reference

18 September 2017

Lian Qian

1

1 reference

18 September 2017

Yong Xu

2

1 reference

18 September 2017

Ted Simper

3

1 reference

18 September 2017

Guowei Jiang

4

1 reference

18 September 2017

Makiko Umezu-Goto

6

1 reference

18 September 2017

Hiroyuki Arai

7

1 reference

18 September 2017

Shuangxing Yu

8

1 reference

18 September 2017

Ryoko Tsukahara

10

1 reference

18 September 2017

Natalia Makarova

11

1 reference

18 September 2017

Yuko Fujiwara

12

1 reference

18 September 2017

Gabor Tigyi

13

1 reference

18 September 2017

Glenn D Prestwich

14

1 reference

18 September 2017

publication date

1 March 2006

1 reference

18 September 2017

1 reference

18 September 2017

volume

1

1 reference

18 September 2017

issue

3

1 reference

18 September 2017

page(s)

376-383

1 reference

Lysophosphatidic acid is a bioactive mediator in ovarian cancer

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

Stereochemical properties of lysophosphatidic acid receptor activation and metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

Structure-activity relationships of lysophosphatidic acid analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

Lysophosphatidic acid: G-protein signalling and cellular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

The emerging role of lysophosphatidic acid in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Lysophosphatidic acid signaling: how a small lipid does big things

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Lysophosphatidic acid production and action: validated targets in cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Synthesis and biological evaluation of phosphonic and thiophosphoric acid derivatives of lysophosphatidic acid

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA1/LPA3 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Initial structure-activity relationships of lysophosphatidic acid receptor antagonists: discovery of a high-affinity LPA1/LPA3 receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Fatty alcohol phosphates are subtype-selective agonists and antagonists of lysophosphatidic acid receptors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Enantioselective responses to a phosphorothioate analogue of lysophosphatidic acid with LPA3 receptor-selective agonist activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Synthesis of alpha-fluorinated phosphonates from alpha-fluorovinylphosphonates: a new route to analogues of lysophosphatidic acid

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Identifying specific conformations by using a carbohydrate scaffold: discovery of subtype-selective LPA-receptor agonists and an antagonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Alkyl lysophosphatidic acid and fluoromethylene phosphonate analogs as metabolically-stabilized agonists for LPA receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Synthesis of optically active 1-acyl-2-O-alkyl-sn-glycero-3-phosphocholine via 1-O-benzyl-sn-glycerol 3-arenesulfonate

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Efficient synthesis of phospholipids from glycidyl phosphates

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

3-Deoxy-D-myo-inositol 1-phosphate, 1-phosphonate, and ether lipid analogues as inhibitors of phosphatidylinositol-3-kinase signaling and cancer cell growth

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Lysophosphatidic acid induces neointima formation through PPARgamma activation.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is Edg-receptor independent.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500042

7 January 2021

Identifiers

DOI

10.1002/CMDC.200500042

1 reference

18 September 2017

1 reference